Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simula

Showing results (21-30 of 296) with videos related to

Pageof 30
Sort By:
Proteomics. Clinical Applications|December 8, 2010
Hepatitis C virus-induced oxidative stress and mitochondrial dysfunction: a focus on recent advances in proteomicsMaria Paola Simula, Valli De Re
Seminars in Cancer Biology|June 29, 2017
The mitochondrial dynamics in cancer and immune-surveillanceLuca Simula, Francesca Nazio, Silvia Campello
Physics Letters. [Part B]|September 28, 2011
OPE, charm-quark mass, and decay constants of D and Ds mesons from QCD sum rulesWolfgang Lucha, Dmitri Melikhov, Silvano Simula
Physical Review. D, Particles and Fields|June 1, 1996
Charge form factor of pi and K mesonsCardarelli, Grach, Narodetskii, et al.
Mutation Research|February 1, 1992
Species differences in the genotoxicity of cyclophosphamide and styrene in three in vivo assaysA P Simula, B G Priestly
Cancers|May 28, 2022
How Phosphofructokinase-1 Promotes PI3K and YAP/TAZ in Cancer: Therapeutic PerspectivesLuca Simula, Marco Alifano, Philippe Icard
Biochimica Et Biophysica Acta. Reviews on Cancer|April 11, 2025
Citrate oscillations during cell cycle are a targetable vulnerability in cancer cellsPhilippe Icard, Marco Alifano, Luca Simula
Trends in Endocrinology and Metabolism: TEM|August 7, 2023
The potential for citrate to reinforce epigenetic therapy by promoting apoptosisPhilippe Icard, Marco Alifano, Luca Simula
Pharmacological Research|June 21, 2019
Targeting Drp1 and mitochondrial fission for therapeutic immune modulationLuca Simula, Michelangelo Campanella, Silvia Campello
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 24, 2012
Subcutaneous nadroparin calcium in the treatment of recent onset retinal vein occlusion: a pilot studyAntonio Pinna, Piera Simula, Angelo Zinellu
Pageof 30

Showing results (21-30 of 296) with videos related to

Sort By:
Pageof 30
Proteomics. Clinical Applications|December 8, 2010
Hepatitis C virus-induced oxidative stress and mitochondrial dysfunction: a focus on recent advances in proteomicsMaria Paola Simula, Valli De Re
Seminars in Cancer Biology|June 29, 2017
The mitochondrial dynamics in cancer and immune-surveillanceLuca Simula, Francesca Nazio, Silvia Campello
Physics Letters. [Part B]|September 28, 2011
OPE, charm-quark mass, and decay constants of D and Ds mesons from QCD sum rulesWolfgang Lucha, Dmitri Melikhov, Silvano Simula
Physical Review. D, Particles and Fields|June 1, 1996
Charge form factor of pi and K mesonsCardarelli, Grach, Narodetskii, et al.
Mutation Research|February 1, 1992
Species differences in the genotoxicity of cyclophosphamide and styrene in three in vivo assaysA P Simula, B G Priestly
Cancers|May 28, 2022
How Phosphofructokinase-1 Promotes PI3K and YAP/TAZ in Cancer: Therapeutic PerspectivesLuca Simula, Marco Alifano, Philippe Icard
Biochimica Et Biophysica Acta. Reviews on Cancer|April 11, 2025
Citrate oscillations during cell cycle are a targetable vulnerability in cancer cellsPhilippe Icard, Marco Alifano, Luca Simula
Trends in Endocrinology and Metabolism: TEM|August 7, 2023
The potential for citrate to reinforce epigenetic therapy by promoting apoptosisPhilippe Icard, Marco Alifano, Luca Simula
Pharmacological Research|June 21, 2019
Targeting Drp1 and mitochondrial fission for therapeutic immune modulationLuca Simula, Michelangelo Campanella, Silvia Campello
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 24, 2012
Subcutaneous nadroparin calcium in the treatment of recent onset retinal vein occlusion: a pilot studyAntonio Pinna, Piera Simula, Angelo Zinellu
Pageof 30